Jack Gauldie

发表

Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma - a phase 1 study

J. Gauldie, Y. Wan, Zhi Hua Li, 2001, Leukemia.

Interleukin 10 gene transfer prevents experimental colitis in rats

C. Hogaboam, G. Barbara, J. Gauldie, 2000, Gut.

Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

J. Gauldie, F. Graham, M. Hitt, 1997, Gene Therapy.

Tgf-1 Gene Transfer to the Mouse Colon Leads to Intestinal Fibrosis

P. Sime, P. Bercik, B. Vallance, 2022 .

Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models.

F. Graham, W. Muller, A. Zlotnik, 1999, Human gene therapy.

TGF-β1 gene transfer to the mouse colon leads to intestinal fibrosis

F. Galeazzi, P. Sime, J. Gauldie, 2005 .

Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice.

J. Gauldie, K. Palmer, S. Gyorffy, 2001, The American journal of pathology.

Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity

M. Hitt, J. Gauldie, K. Palmer, 2001, Gene Therapy.

Endogenous interleukin‐6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice

J. Gauldie, M. Ramer, P. Richardson, 1999, The European journal of neuroscience.

Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery.

J. Gauldie, K. Teoh, C. Bradley, 1995, Circulation.

Immunization with adenovirus at the large intestinal mucosa as an effective vaccination strategy against sexually transmitted viral infection

J. Gauldie, S. Collins, M. McDermott, 2008, Mucosal Immunology.

The use of adenoviral vectors for gene therapy and gene transfer in vivo.

F. Graham, J. Gauldie, J. Bramson, 1995, Current opinion in biotechnology.

Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin‐10 on organ allograft and tumour rejection

J. Fung, L. Lu, A. Thomson, 2000, Immunology.

Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta.

P. Robbins, L. Lu, A. Thomson, 1998, Transplantation.

Spatial-specific TGF-beta1 adenoviral expression determines morphogenetic phenotypes in embryonic mouse lung.

D. Warburton, D. Bu, S. Buckley, 1999, European journal of cell biology.

Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12

W. Muller, J. Gauldie, R. Foley, 2001, Gene Therapy.

Intramarrow cytokine gene transfer by adenoviral vectors in dogs.

F. Graham, R. Carter, J. Gauldie, 1997, Human gene therapy.

Progress towards international reference standards for human serum proteins.

W. H. Hannon, R. Ritchie, L. van Es, 1978, Journal of biological standardization.

Role of Epidermal Cell Thymocyte‐Activating Factor in the Proliferation and Differentiation of Murine B Cells

J. Gauldie, S. Reynolds, P. S. Pillai, 1987, Journal of leukocyte biology.

Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression.

F. Graham, W. Muller, B. Pützer, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12.

F. Graham, J. Gauldie, K. Rosenthal, 1996, Human gene therapy.

Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNFα

W. Muller, J. Gauldie, F. Graham, 1997, Gene Therapy.

A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model.

F. Graham, J. Gauldie, J. Bramson, 1998, Journal of immunology.